• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Chain Bridge I

    11/12/24 4:02:56 PM ET
    $CBRG
    Blank Checks
    Finance
    Get the next $CBRG alert in real time by email
    SC 13G/A 1 d800271dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

     

    Chain Bridge I

    (Name of Issuer)

    Class A ordinary shares, par value $0.0001 per share

    (Title of Class of Securities)

    G2061X102

    (CUSIP Number)

    September 30, 2024

    (Date of Event which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    SCHEDULE 13G

    CUSIP No. G2061X102

     

     1   

     Names of Reporting Persons

     

     Periscope Capital Inc.

     2  

     Check the appropriate box if a member of a Group (see instructions)

     (a) ☐  (b) ☒

     

     3  

     Sec Use Only

     

     4  

     Citizenship or Place of Organization

     

     Canada

    Number of

    Shares

    Beneficially 

    Owned by

    Each

    Reporting

    Person

    With:

       5    

     Sole Voting Power

     

       6   

     Shared Voting Power

     

     0

       7   

     Sole Dispositive Power

     

       8   

     Shared Dispositive Power

     

     0

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     0

    10  

     Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

     

     ☐

    11  

     Percent of class represented by amount in row (9)

     

     0.0%

    12  

     Type of Reporting Person (See Instructions)

     

     FI

     

    Page 2 of 5


    Item 1.

     

    (a)

    Name of Issuer:

    Chain Bridge I

     

    (b)

    Address of Issuer’s Principal Executive Offices:

    8 The Green # 17538, Dover, DE, 19901

     

    Item 2.

     

    (a)

    Name of Person Filing:

    This Schedule 13G is being filed on behalf of Periscope Capital Inc. (“Periscope”) with respect to the shares of Class A ordinary shares, par value $0.0001 per share (the “Common Stock”), of Chain Bridge I, a Cayman Islands exempted company (the “Issuer”).

    Periscope, which is the beneficial owner of 0 shares of Common Stock, acts as investment manager of, and exercises investment discretion with respect to, certain private investment funds (each, a “Periscope Fund”) that collectively directly own 0 shares of Common Stock.

    The filing of this statement should not be construed as an admission that Periscope is, for the purpose of Section 13 of the Act, the beneficial owner of the Common Stock owned by the Periscope Funds.

     

    (b)

    Address of Principal Business Office or, if None, Residence:

    333 Bay Street, Suite 1240, Toronto, Ontario, Canada M5H 2R2

     

    (c)

    Citizenship:

    See Row 4 of the Cover Page.

     

    (d)

    Title and Class of Securities:

    Class A ordinary shares, par value $0.0001 per share

     

    (e)

    CUSIP No.:

    G2061X102

     

    Item 3.

    If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

       (a)    ☐    Broker or dealer registered under Section 15 of the Act;
       (b)    ☐    Bank as defined in Section 3(a)(6) of the Act;
          (c)    ☐    Insurance company as defined in Section 3(a)(19) of the Act;
       (d)    ☐    Investment company registered under Section 8 of the Investment Company Act of 1940;
       (e)    ☐    An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
       (f)    ☐    An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
       (g)    ☐    A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
       (h)    ☐    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
       (i)    ☐    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;
       (j)    ☒    A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);
       (k)    ☐    Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

     

    Page 3 of 5


    If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Non-U.S. investment adviser.

     

    Item 4.

    Ownership

    The information required by Items 4(a)-(c) is set forth in Rows 5-11 of the Cover Page and is incorporated herein by reference.

    Periscope expressly declares that this filing shall not be construed as an admission that it is, for the purposes of Sections 13(d) or 13(g) of the Act, the beneficial owner of the securities owned by the Periscope Funds.

     

    Item 5.

    Ownership of Five Percent or Less of a Class.

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☒.

     

    Item 6.

    Ownership of more than Five Percent on Behalf of Another Person.

    Not applicable.

     

    Item 7.

    Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person.

    Not applicable.

     

    Item 8.

    Identification and classification of members of the group.

    Not applicable.

     

    Item 9.

    Notice of Dissolution of Group.

    Not applicable.

     

    Item 10.

    Certifications.

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

    Page 4 of 5


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: November 11, 2024

     

    PERISCOPE CAPITAL INC.
    By:   /s/ Lisa Shostack
    Lisa Shostack, General Counsel

    The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of this filing person), evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

    Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).

     

    Page 5 of 5

    Get the next $CBRG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CBRG

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CBRG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Kucharchuk Andrew Albert

      3 - Chain Bridge I (0001845149) (Issuer)

      4/5/24 4:19:27 PM ET
      $CBRG
      Blank Checks
      Finance
    • SEC Form 3 filed by new insider Wiener Oliver

      3 - Chain Bridge I (0001845149) (Issuer)

      2/22/24 4:13:59 PM ET
      $CBRG
      Blank Checks
      Finance
    • New insider Cb Co-Investment Llc claimed ownership of 575,665 units of Class A Ordinary Shares (SEC Form 3)

      3 - Chain Bridge I (0001845149) (Issuer)

      2/20/24 7:34:04 PM ET
      $CBRG
      Blank Checks
      Finance

    $CBRG
    SEC Filings

    See more
    • SEC Form 10-Q filed by Chain Bridge I

      10-Q - Chain Bridge I (0001845149) (Filer)

      11/19/24 5:29:41 PM ET
      $CBRG
      Blank Checks
      Finance
    • Chain Bridge I filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

      8-K - Chain Bridge I (0001845149) (Filer)

      11/19/24 6:05:29 AM ET
      $CBRG
      Blank Checks
      Finance
    • SEC Form NT 10-Q filed by Chain Bridge I

      NT 10-Q - Chain Bridge I (0001845149) (Filer)

      11/14/24 5:29:34 PM ET
      $CBRG
      Blank Checks
      Finance

    $CBRG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Phytanix Bio Publishes New Investor Deck Highlighting Strategic Vision and Growth Potential

      NEW YORK and SANTA BARBARA, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Phytanix Bio, a pioneering preclinical stage pharmaceutical company dedicated to the development of therapeutics based on cannabinoid and cannabinoid-like molecules, today announced the release of its new investor deck. The updated presentation provides an in-depth look at the company's strategic vision, scientific advancements, and growth potential as it progresses towards the development of next-generation cannabinoid medicines. The global cannabis pharmaceuticals market size was estimated at USD 3.4 billion in 2023 and is anticipated to grow at a CAGR of 53.3% from 2024 to 2030. The investor deck is now available on

      7/30/24 9:00:00 AM ET
      $CBRG
      Blank Checks
      Finance
    • Chain Bridge I to Acquire Phytanix Bio, Creating a New Public Company Focused on Developing Next Generation Cannabinoid and Cannabinoid-like Medicines

      Phytanix Bio is a preclinical stage pharmaceutical company founded by former members and associates of GW Pharmaceuticals, holding exclusive cannabinoid and cannabinoid-like medicine intellectual property (IP)The transaction reflects a pre-deal valuation of $58 million for Phytanix Bio plus the assumption of $17 million of preferred stock and $4.4 million of short-term debt that will be exchanged for convertible preferred stock at deal closeThe business combination is expected to be completed in the fourth quarter of 2024, with the combined company to be listed on Nasdaq Capital Markets under the ticker "PHYX" NEW YORK and SANTA BARBARA, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Phytani

      7/22/24 5:45:34 PM ET
      $CBRG
      Blank Checks
      Finance
    • Chain Bridge I Will Redeem Public Shares

      Chain Bridge I (the "Company") (NASDAQ:CBRGU, CBRG, CBRGW))), a special purpose acquisition company, today announced that it will redeem all of its outstanding Class A ordinary shares, par value $0.0001 (the "Public Shares"), effective as of the close of business on November 15, 2023, as the Company will not consummate an initial business combination within the time period required by its Amended and Restated Memorandum and Articles of Association (the "Articles"). The Company concluded it would be unable to meet its expectations for quality and long-term return potential by completing an initial business combination by November 15, 2023 (twenty-four months from the closing of the Company

      10/31/23 4:00:00 PM ET
      $CBRG
      Blank Checks
      Finance

    $CBRG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Chain Bridge I

      SC 13G/A - Chain Bridge I (0001845149) (Subject)

      11/14/24 1:46:48 PM ET
      $CBRG
      Blank Checks
      Finance
    • Amendment: SEC Form SC 13G/A filed by Chain Bridge I

      SC 13G/A - Chain Bridge I (0001845149) (Subject)

      11/14/24 12:49:36 PM ET
      $CBRG
      Blank Checks
      Finance
    • Amendment: SEC Form SC 13G/A filed by Chain Bridge I

      SC 13G/A - Chain Bridge I (0001845149) (Subject)

      11/13/24 4:37:52 PM ET
      $CBRG
      Blank Checks
      Finance